Answers are grounded in this paper and cite their sources.
Cohort analysis reveals Karnofsky Performance Status and timing linked to prolonged progression-free survival in r/rPCNSL.
BACKGROUND An interim analysis of ROSETTA (jRCT1021230006), a cohort study conducted in Japan, indicated favorable effectiveness and manageable safety of tirabrutinib for relapsed or refractory primary central nervous system lymphoma (r/rPCNSL) in a real-world setting. We analyzed patient characteristics influencing prolonged effectiveness of tirabrutinib. This is an encore presentation including new data of real-world progression-free survival (rwPFS) by the interval from the end of previous treatment. METHODS We analyzed rwPFS by patient characteristics in 137 patients with r/rPCNSL who started tirabrutinib treatment between November 2020 and April 2022. RESULTS Patients with one prior treatment (n = 90) had a numerically longer rwPFS compared to those with ≥2 prior treatments (n = 47; median, 16.3 vs 8.2 months), with a hazard ratio (HR) of 1.50 (1 vs ≥2; 95% confidence interval [CI], 0.94–2.39). The median rwPFS in patients with a Karnofsky Performance Status (KPS) score of 80–100 (n = 34; 11.0 months) was similar to that of 50–70 (n = 63; 10.7 months) with a HR of 0.87 (80–100 vs 50–70; 95% CI, 0.51–1.49) but numerically longer than that of 10–40 (n = 15; 2.3 months) with a HR of 1.68 (80–100 vs 10–40; 95% CI, 0.80–3.56). Additionally, the median rwPFS was numerically longer in patients with an interval of ≥1 year from the end of previous treatment to the start of tirabrutinib treatment (n = 46) than in patients with the interval of <1 year (n = 89; 15.6 vs 11.0 months), with a HR of 0.75 (<1 vs ≥1; 95% CI, 0.45–1.24). CONCLUSION These data showed a tendency for prolonged rwPFS in patients with one prior treatment, a baseline KPS score of ≥50, or the interval of ≥1 year prior to the start of tirabrutinib treatment.
No takes yet. Share an insight, caveat, or question.
Yamasaki et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: